XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated other comprehensive (loss) income
Accumulated other comprehensive (loss) income, Foreign currency translation
Accumulated other comprehensive (loss) income, Defined benefit pension plans
Treasury stock
Balance at the beginning of the year at Dec. 31, 2023   $ 2,709 $ 1,168,694 $ 9,940,343   $ (298,835) $ (186,107) $ (1,896,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   7            
Issuance of common stock under employee stock plans     19,556         6,319
Share-based compensation expense     22,164          
Net income $ 648,626     648,626        
Cash dividends paid       (129,411)        
Other       (2)        
Translation adjustments           (50,821)    
Change in long-term intercompany notes           (4,048)    
Net investment hedge instruments (loss) gain , net of tax of $17,857 and $(930) for the quarter ended June 30, 2025 and 2024 and $25,956 and $(4,917) for the six months ended June 30, 2025 and 2024, respectively           15,098    
Amortization of net actuarial loss and other, net of tax of $(296) and $(365) for the quarter ended June 30, 2025 and 2024 and $(592) and $(730) for the six months ended June 30, 2025 and 2024, respectively             2,320  
Purchase of treasury stock               (7,595)
Balance at the end of the year at Jun. 30, 2024 9,252,404 2,716 1,210,414 10,459,556 $ (522,393) (338,606) (183,787) (1,897,889)
Balance at the beginning of the year at Mar. 31, 2024   2,715 1,186,132 10,186,621   (325,381) (184,947) (1,896,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   1            
Issuance of common stock under employee stock plans     11,059         (284)
Share-based compensation expense     13,223          
Net income 337,683     337,683        
Cash dividends paid       (64,747)        
Other       (1)        
Translation adjustments           (16,706)    
Change in long-term intercompany notes           625    
Net investment hedge instruments (loss) gain , net of tax of $17,857 and $(930) for the quarter ended June 30, 2025 and 2024 and $25,956 and $(4,917) for the six months ended June 30, 2025 and 2024, respectively           2,856    
Amortization of net actuarial loss and other, net of tax of $(296) and $(365) for the quarter ended June 30, 2025 and 2024 and $(592) and $(730) for the six months ended June 30, 2025 and 2024, respectively             1,160  
Purchase of treasury stock               (680)
Balance at the end of the year at Jun. 30, 2024 9,252,404 2,716 1,210,414 10,459,556 (522,393) (338,606) (183,787) (1,897,889)
Balance at the beginning of the year at Dec. 31, 2024 9,655,304 2,720 1,264,670 11,057,684   (392,133) (163,606) (2,114,031)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   3            
Issuance of common stock under employee stock plans     (11,188)         12,814
Share-based compensation expense     22,313          
Net income 710,125     710,125        
Cash dividends paid       (142,960)        
Other       0        
Translation adjustments           235,991    
Change in long-term intercompany notes           (5,843)    
Net investment hedge instruments (loss) gain , net of tax of $17,857 and $(930) for the quarter ended June 30, 2025 and 2024 and $25,956 and $(4,917) for the six months ended June 30, 2025 and 2024, respectively           (82,694)    
Amortization of net actuarial loss and other, net of tax of $(296) and $(365) for the quarter ended June 30, 2025 and 2024 and $(592) and $(730) for the six months ended June 30, 2025 and 2024, respectively             1,884  
Purchase of treasury stock               (7,077)
Balance at the end of the year at Jun. 30, 2025 10,388,672 2,723 1,275,795 11,624,849 (406,401) (244,679) (161,722) (2,108,294)
Balance at the beginning of the year at Mar. 31, 2025   2,722 1,255,018 11,337,987   (355,272) (162,664) (2,107,845)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   1            
Issuance of common stock under employee stock plans     7,928         (338)
Share-based compensation expense     12,849          
Net income 358,367     358,367        
Cash dividends paid       (71,505)        
Other       0        
Translation adjustments           170,213    
Change in long-term intercompany notes           (2,727)    
Net investment hedge instruments (loss) gain , net of tax of $17,857 and $(930) for the quarter ended June 30, 2025 and 2024 and $25,956 and $(4,917) for the six months ended June 30, 2025 and 2024, respectively           (56,893)    
Amortization of net actuarial loss and other, net of tax of $(296) and $(365) for the quarter ended June 30, 2025 and 2024 and $(592) and $(730) for the six months ended June 30, 2025 and 2024, respectively             942  
Purchase of treasury stock               (111)
Balance at the end of the year at Jun. 30, 2025 $ 10,388,672 $ 2,723 $ 1,275,795 $ 11,624,849 $ (406,401) $ (244,679) $ (161,722) $ (2,108,294)